CAMP4 Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . CAMP4 THERAPEUTICS PORATION
CAMP Stock  USD 5.37  0.18  3.24%   
CAMP4 THERAPEUTICS financial statements provide useful quarterly and yearly information to potential CAMP4 THERAPEUTICS PORATION investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on CAMP4 THERAPEUTICS financial statements helps investors assess CAMP4 THERAPEUTICS's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CAMP4 THERAPEUTICS's valuation are summarized below:
Gross Profit
-37.9 M
Market Capitalization
102.8 M
Enterprise Value Revenue
315.3074
Earnings Share
(2.64)
There are currently one hundred twenty fundamental signals for CAMP4 THERAPEUTICS PORATION that can be evaluated and compared over time across rivals. Investors and active traders are advised to validate CAMP4 THERAPEUTICS's prevailing fundamental performance against the performance between 2010 and 2025 to make sure the trends are evolving in the right direction. As of 03/18/2025, Market Cap is likely to grow to about 7 B. Also, Enterprise Value is likely to grow to about 7.1 B

CAMP4 THERAPEUTICS Total Revenue

217.12 Million

Check CAMP4 THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CAMP4 THERAPEUTICS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17.8 M, Interest Expense of 8.3 M or Selling General Administrative of 36.9 M, as well as many indicators such as Price To Sales Ratio of 1.26, Ptb Ratio of 70.11 or Capex To Depreciation of 0.84. CAMP4 financial statements analysis is a perfect complement when working with CAMP4 THERAPEUTICS Valuation or Volatility modules.
  
Check out the analysis of CAMP4 THERAPEUTICS Correlation against competitors.

CAMP4 THERAPEUTICS Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets47 M49.5 M394.7 M
Slightly volatile
Short and Long Term Debt Total243.1 M276.5 M234.7 M
Pretty Stable
Total Current Liabilities6.7 M7 M96.3 M
Slightly volatile
Property Plant And Equipment Net11.4 M12 M59.5 M
Slightly volatile
Current Deferred Revenue23.9 M22.9 M31.5 M
Slightly volatile
Net Debt154.3 M228.3 M142.9 M
Slightly volatile
Accounts Payable890.9 K937.8 K25.5 M
Slightly volatile
Cash57.8 M34.5 M88.8 M
Slightly volatile
Non Current Assets Total12.8 M13.4 M203.5 M
Slightly volatile
Non Currrent Assets Other1.4 M1.5 M21.6 M
Slightly volatile
Cash And Short Term Investments64.6 M37.7 M89.6 M
Slightly volatile
Net Receivables77 M95.4 M74.1 M
Slightly volatile
Good Will77.9 M84.8 M100.2 M
Slightly volatile
Liabilities And Stockholders Equity340.3 M342.1 M451.6 M
Slightly volatile
Non Current Liabilities Total179.8 M153.8 M224.1 M
Slightly volatile
Inventory20.5 M21.5 M31.2 M
Slightly volatile
Other Current Assets272.7 K287.1 K18 M
Slightly volatile
Other Stockholder Equity176.2 M166.2 M212 M
Slightly volatile
Total Liabilities249.2 M160.8 M324.3 M
Slightly volatile
Total Current Assets34.2 M36 M191.2 M
Slightly volatile
Short Term Debt602.8 K634.5 K21.3 M
Slightly volatile
Intangible Assets28.4 M24 M39.6 M
Slightly volatile
Common Stock393.2 K430.1 K357.1 K
Slightly volatile
Common Stock Shares Outstanding39.3 M42.6 M35.5 M
Slightly volatile
Capital Lease Obligations9.6 M10.5 M12.1 M
Slightly volatile
Property Plant And Equipment Gross15.1 M16 M19.2 M
Slightly volatile
Capital Stock800900981
Slightly volatile
Net Working Capital43.5 M29 M68.7 M
Slightly volatile

CAMP4 THERAPEUTICS Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization17.8 M19.6 M21.6 M
Slightly volatile
Interest Expense8.3 M4.2 M13.1 M
Slightly volatile
Selling General Administrative36.9 M28.3 M46.3 M
Slightly volatile
Selling And Marketing Expenses34.3 M26.6 M43.4 M
Slightly volatile
Total Revenue217.1 M167.6 M284.8 M
Slightly volatile
Gross Profit84.1 M60.3 M111.8 M
Slightly volatile
Other Operating Expenses226.2 M175.5 M290.8 M
Slightly volatile
Research Development18.7 M13.2 M24 M
Slightly volatile
Cost Of Revenue133.1 M107.3 M173 M
Slightly volatile
Total Operating Expenses93.1 M68.1 M117.8 M
Slightly volatile
Net Interest Income2 M3.2 M1.2 M
Slightly volatile
Interest Income2 M3.2 M1.2 M
Slightly volatile
Reconciled Depreciation1.4 M1.9 M1 M
Slightly volatile

CAMP4 THERAPEUTICS Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.5 M2.6 M10.3 M
Slightly volatile
Begin Period Cash Flow99.6 M76.1 M194.2 M
Slightly volatile
Depreciation1.4 M1.5 M24.4 M
Slightly volatile
Other Non Cash Items1.6 M1.6 M23.5 M
Slightly volatile
Capital Expenditures579.7 K610.2 K16.2 M
Slightly volatile
End Period Cash Flow58.1 M36 M89 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.261.3332.2692
Slightly volatile
PTB Ratio70.1148.3395.8795
Very volatile
Capex To Depreciation0.840.80.6229
Pretty Stable
PB Ratio70.1148.3395.8795
Very volatile
Inventory Turnover5.495.457.5629
Slightly volatile
Payables Turnover9.569.017.6004
Slightly volatile
Sales General And Administrative To Revenue0.0960.150.1265
Slightly volatile
Research And Ddevelopement To Revenue0.06380.0710.0799
Slightly volatile
Intangibles To Total Assets0.180.280.2464
Slightly volatile
Current Ratio1.911.762.5448
Slightly volatile
Receivables Turnover8.135.835.9246
Slightly volatile
Debt To Equity0.881.532.004
Slightly volatile
Revenue Per Share4.734.537.407
Very volatile
Debt To Assets0.450.430.3187
Slightly volatile
Days Sales Outstanding43.3764.8565.9964
Slightly volatile
Book Value Per Share2.093.713.3605
Very volatile
Stock Based Compensation To Revenue0.01580.03050.0247
Slightly volatile
EV To Sales23.6518.5236.0392
Slightly volatile
Days Of Inventory On Hand68.369.2952.5229
Pretty Stable
Capex To Revenue0.03580.06970.0343
Slightly volatile
Cash Per Share3.032.892.5443
Slightly volatile
Days Payables Outstanding39.1241.9554.2609
Slightly volatile
Shareholders Equity Per Share2.083.713.3598
Very volatile
Capex Per Share0.630.60.3078
Slightly volatile
Interest Debt Per Share7.196.844.3723
Slightly volatile
Enterprise Value Over EBITDA5364461.3 K
Pretty Stable
Graham Number3.756.646.641
Pretty Stable
Price Book Value Ratio70.1148.3395.8795
Very volatile
Company Equity Multiplier2.423.244.2299
Slightly volatile
Long Term Debt To Capitalization0.560.530.4534
Slightly volatile
Total Debt To Capitalization0.60.570.438
Slightly volatile
Debt Equity Ratio0.881.532.004
Slightly volatile
Quick Ratio1.451.492.1232
Slightly volatile
Net Income Per E B T0.720.910.998
Pretty Stable
Cash Ratio0.630.81.0315
Very volatile
Price To Book Ratio70.1148.3395.8795
Very volatile
Fixed Asset Turnover4.094.3120.2714
Slightly volatile
Debt Ratio0.450.430.3187
Slightly volatile
Price Sales Ratio1.261.3332.2692
Slightly volatile
Asset Turnover1.620.851.0861
Slightly volatile
Gross Profit Margin0.250.320.3612
Very volatile
Price Fair Value70.1148.3395.8795
Very volatile
Operating Cycle128152121
Slightly volatile
Days Of Payables Outstanding39.1241.9554.2609
Slightly volatile
Cash Conversion Cycle79.9998.5565.1209
Pretty Stable
Days Of Inventory Outstanding68.369.2952.5229
Pretty Stable
Days Of Sales Outstanding43.3764.8565.9964
Slightly volatile
Enterprise Value Multiple5364461.3 K
Pretty Stable

CAMP4 THERAPEUTICS Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap7 B6.7 B8.7 B
Slightly volatile
Enterprise Value7.1 B6.8 B8.8 B
Slightly volatile

CAMP4 Upcoming Events

25th of April 2024
Upcoming Quarterly Report
View
8th of July 2024
Next Financial Report
View
29th of February 2024
Next Fiscal Quarter End
View
25th of April 2024
Next Fiscal Year End
View
30th of November 2023
Last Quarter Report
View
28th of February 2023
Last Financial Announcement
View

About CAMP4 THERAPEUTICS Financial Statements

CAMP4 THERAPEUTICS shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although CAMP4 THERAPEUTICS investors may analyze each financial statement separately, they are all interrelated. The changes in CAMP4 THERAPEUTICS's assets and liabilities, for example, are also reflected in the revenues and expenses on on CAMP4 THERAPEUTICS's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue22.9 M23.9 M
Total Revenue167.6 M217.1 M
Cost Of Revenue107.3 M133.1 M
Sales General And Administrative To Revenue 0.15  0.10 
Research And Ddevelopement To Revenue 0.07  0.06 
Revenue Per Share 4.53  4.73 
Stock Based Compensation To Revenue 0.03  0.02 
Capex To Revenue 0.07  0.04 
Ebit Per Revenue(0.05)(0.05)

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY